Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Treating KRAS-Mutated mCRC

Ibrahim Sahin

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSM…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With …

2024 ASCO® Annual Meeting Insights Hub

D. Modest

Treating BRAF-Mutated mCRC

Ibrahim Sahin

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

2024 ASCO® Annual Meeting Insights Hub

C. Eng

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Baseline…

Insights from 2023 ASCO® Annual Meeting

S. Stintzing

ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…

Van Morris

C. Eng

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implications…

Insights from 2024 ASCO® GI Annual Meeting

Y. Janjigian, S. Cytryn, S. Klempner

ESMO 2024 Insights: The Value of Immune Checkpoint Blockade in MSS/p…

2024 ESMO Annual Meeting Insights Hub

B. Geisler

Treatment of mCRC After Standard Chemotherapy

UChicago Medicine

A. Shergill